False-Negative Neuroendocrine Tumor Identified With 68Ga-DOTATOC PET/CT: A Case of Well-Differentiated Somatostatinoma.

MLA

Moreau, Aurélie, et al. “False-Negative Neuroendocrine Tumor Identified With 68Ga-DOTATOC PET/CT: A Case of Well-Differentiated Somatostatinoma.” Clinical Nuclear Medicine, vol. 49, no. 8, Aug. 2024, pp. 764–66. EBSCOhost, https://doi.org/10.1097/RLU.0000000000005241.

APA

Moreau, A., Chaouat, C., Walter, T., Dupré, A., & Kryza, D. (2024). False-Negative Neuroendocrine Tumor Identified With 68Ga-DOTATOC PET/CT: A Case of Well-Differentiated Somatostatinoma. Clinical Nuclear Medicine, 49(8), 764–766. https://doi.org/10.1097/RLU.0000000000005241

Chicago

Moreau, Aurélie, Charlotte Chaouat, Thomas Walter, Aurélien Dupré, and David Kryza. 2024. “False-Negative Neuroendocrine Tumor Identified With 68Ga-DOTATOC PET/CT: A Case of Well-Differentiated Somatostatinoma.” Clinical Nuclear Medicine 49 (8): 764–66. doi:10.1097/RLU.0000000000005241.